Powder: -20°C for 3 years
In solvent: -80°C for 2 years
Regorafénib N-oxyde M2 is an active metabolite of Regorafenib. Regorafenib is a multi-target inhibitor for VEGFR1/2/3, PDGFRβ, RET, Kit, and Raf-1 (IC50s: 13/4.2/46, 1.5, 22, 7, and 2.5 nM).
Description | Regorafénib N-oxyde M2 is an active metabolite of Regorafenib. Regorafenib is a multi-target inhibitor for VEGFR1/2/3, PDGFRβ, RET, Kit, and Raf-1 (IC50s: 13/4.2/46, 1.5, 22, 7, and 2.5 nM). |
Targets&IC50 | VEGFR1:13nM , RET:22nM , VEGFR2:4.2nM , VEGFR3:46nM , Raf-1:2.5 nM , PDGFRβ:1.5nM , Kit:7nM |
Synonyms | 瑞戈非尼杂质 13 |
Molecular Weight | 498.82 |
Formula | C21H15ClF4N4O4 |
CAS No. | 835621-11-9 |
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
DMSO: 10 mM
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Regorafénib N-oxyde (M2) 835621-11-9 MAPK信号通路 代谢 蛋白酪氨酸激酶 凋亡 血管生成 c-Kit c-RET Drug Metabolite PDGFR Raf VEGFR Inhibitor Regorafénib N oxyde (M2) Regorafénib Noxyde (M2) inhibit Regorafénib N-oxyde (M-2) Platelet-derived growth factor receptor inhibitor